3D Printing for Medical Innovations
When
March 25, 2025
5:30 - 7:30 PM
Where
Online or at the CIC in Cambridge, MA
Join MDG Boston and Hamilton Brook Smith Reynolds for an expert panel discussion on 3D printing innovations in the medical field.
Join us for an exciting and informative event focused on the transformative impact of 3D printing in the medical device industry. This event will bring together industry leaders, innovators, and experts to explore the latest advancements, intellectual property protection strategies, business models, and emerging trends in 3D printing for medical applications.
Highlights of the Event:
- Medical Innovations Made by 3D Printing: Discover groundbreaking medical devices and solutions created with 3D printing technology. From custom prosthetics and implants to bioengineered tissues and organs, learn how 3D printing is revolutionizing patient care and treatment options.
- Business Models in 3D Printing: Discover various business models such as rapid prototyping services, small batch manufacture of finished medical devices, and long-term manufacture of patient-specific finished medical devices. Learn about recent deal activity related to 3D Printing.
- Latest Trends in 3D Printing:Stay ahead of the curve with an overview of the latest trends and advancements in 3D printing technology. Topics will include advancements in materials science, new printing techniques, and the integration of automation and machine learning in 3D printing processes.
- Intellectual Property Protection and Strategies: Gain insights into the critical aspects of protecting intellectual property (IP) in the rapidly evolving field of 3D printing. Experts will discuss best practices for securing patents and developing robust IP strategies to safeguard your innovations.
- Question and Answer Session: Engage with our panel of experts during an interactive Q&A session. This is your opportunity to ask questions, share your thoughts, and gain valuable insights from industry leaders.
Don’t miss this opportunity to connect with peers, learn from experts, and explore the future of 3D printing in the medical device industry. Register now to secure your spot!
Speakers
Christopher Chen, MD Ph.D., Boston University
Dr. Chen is studying how the cooperation between adhesive, mechanical, and biochemical signaling drives tissues to organize during development, adapt to physical stresses, and devolve during disease. His lab examines these questions through the development and application of innovative technologies to control how cells interact with their surroundings, advancing numerous technologies from microfluidics, microelectromechanical systems (MEMS), nanofabrication, mechanobiology, biomaterials, and synthetic and stem cell biology. Insights from these efforts apply to the biology and engineering of stem cells, tissue vascularization, cardiac tissue, and cancer.
Mitch Debora, CEO of Mosaic Manufacturing Mitch Debora is a Co-Founder & the CEO at Mosaic Manufacturing - a digital manufacturing company powering next generation supply chains with mass scale additive manufacturing solutions. Mitch is an expert and advisor in the area of additive manufacturing and currently sits as an AM Advisory Board Member at NGen. Mitch is a mechanical and materials engineer having completed his undergraduate degree at Queen’s University.
Peter Meyer, Managing Director of Outcome Capital
Peter serves as Managing Director of Outcome Capital LLC, a highly specialized Boston-based strategic advisory and investment banking group providing capital raising and M&A services to growth-stage life science companies. He has over 25 years of strategic investment and commercial execution experience in MedTech and the Life Sciences and brings a professional focus on leveraging industry best-practices for strategy development, market entry, and growth acceleration. He has represented buy-side and sell-side interests across a wide range of clinical segments and business models, closing well over $3B in acquisition, partnership, and equity investments.
Moderator
Alexander Adam, Ph.D., Principal at Hamilton Brook Smith Reynolds
Alex specializes in drafting and prosecuting patent applications in the fields of computer systems, electronics, imaging software, control systems, mechanical devices, medical devices, telecommunications, and clean energy. He also has experience in patent litigation, due diligence, and providing invalidity and non-infringement opinions. Alex advises clients on U.S. and international patent strategy.